Evidence map›Paper›PMID 32012723›Full record

ArticleBrain sciences2020

Lemur Tyrosine Kinase 2 (LMTK2) Level Inversely Correlates with Phospho-Tau in Neuropathological Stages of Alzheimer's Disease.

János Bencze, Máté Szarka, Viktor Bencs, Renáta Nóra Szabó, László V Módis, Dag Aarsland, Tibor Hortobágyi

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. LMTK2 and CRB1 are two novel risk genes for Alzheimer's disease in Han Chinese.The journal of prevention of Alzheimer's disease · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

János BenczeDepartment of Pathology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Máté SzarkaHorvath Csaba Memorial Institute of Bioanalytical Research, Research Centre for Molecular Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Viktor BencsDepartment of Pathology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Renáta Nóra SzabóMTA-DE Cerebrovascular and Neurodegenerative Research Group, Department of Neurology, University of Debrecen, 4032 Debrecen, Hungary.
László V MódisMTA-DE Cerebrovascular and Neurodegenerative Research Group, Department of Neurology, University of Debrecen, 4032 Debrecen, Hungary.
Dag AarslandDepartment of Old Age Psychiatry, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.
Tibor HortobágyiMTA-DE Cerebrovascular and Neurodegenerative Research Group, Department of Neurology, University of Debrecen, 4032 Debrecen, Hungary.
University of Debrecen · HUKing's College London · GB

Funding

EMBERI ERŐFORRÁS FEJLESZTÉSI OPERATÍV PROGRAM (EFOP) EFOP-3.6.3-VEKOP-16-2017-00009Gazdaságfejlesztési és Innovációs Operatív Program (GINOP) GINOP-2.3.2-15-2016-00043Hungarian Brain Research Program 2017-1.2.1-NKP-2017-00002Hungarian Ministry of Innovation and Technologies, New National Excellence Program ÚNKP-19-3, ÚNKP-19-2SZTE ÁOK-KKA 5S 567 (A202)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer’s diseasedigital image analysisLMTK2neurodegenerationtau

Identifiers

PMID32012723
PMCPMC7071479
OpenAlexW3002276674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.